Efectos de la oxigenoterapia hiperbárica en las fístulas perianales de la enfermedad de Crohn: resultados clínicos y tasas de remisión
- Autores:G. Piotrowicz, A. Rudnik, J. Kot, A. Babicki, P. Banaszkiewicz, A. Piotrowicz, M. Rzeszutek, P. Zientara, J. Adamska-Mieruszewska, G. Rydzewska
- Fecha de publicación:January 9, 2025
- Tipo:Articulos
Abstract
Crohn’s disease (CD) is a chronic inflammatory bowel disorder with debilitating complications such as perianal fistulas, affecting 14-38% of patients (1). Conventional treatments often achieve limited success, necessitating adjunctive approaches (2,3). Hyperbaric Oxygen Therapy (HBOT), known for its wound-healing and anti-inflammatory properties, has emerged as a potential therapy for complex CD cases (4,5). This study evaluates the efficacy of HBOT in combination with standard treatments for reducing perianal fistula activity and achieving clinical remission in patients with CD.